MDS Analytical Technologies has launched the six-channel and two-channel versions of the Spectramax L, a multiple photomultiplier-based platform for microplate luminometers.
They are designed for drug discovery scientists who screen small molecules for biological activity, and life sciences researchers who investigate protein-protein interactions.
The six-channel Spectramax L microplate reader system reads 96-well and 384-well microplates six times faster than conventional microplate luminometers.
The two-channel instrument reads flash and glow luminescence twice as fast as conventional microplate luminometers, and allows bioluminescence resonance energy transfer (BRET) assays for proteomics studies.
'The higher throughput of the six-channel instrument will allow small biotech and pharmaceutical companies a cost-effective approach to medium-throughput, Aequorin-based, G protein-coupled receptor (GPCR) and luciferase-based reporter gene screening,' said Andy Boorn, president of MDS Analytical Technologies.
'Large pharmaceutical companies will benefit by using the reader to validate and optimise assays prior to large-scale screening campaigns.' MDS Analytical Technologies expects the six-channel and two-channel versions of the Spectramax L microplate reader to be available for shipment in March 2009.
